ZBIO logo

ZBIO
Zenas Biopharma Inc.

832
Mkt Cap
$1.41B
Volume
46,938.00
52W High
$44.60
52W Low
$6.11
PE Ratio
-5.82
ZBIO Fundamentals
Price
$25.59
Prev Close
$26.35
Open
$25.04
50D MA
$25.71
Beta
1.41
Avg. Volume
1.32M
EPS (Annual)
-$3.76
P/B
5.66
Rev/Employee
$38,461.54
$7.56
Loading...
Loading...
News
all
press releases
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Recommendation of "Moderate Buy" by Analysts
Shares of Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight analysts that are currently covering the company, MarketBeat reports...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded shares of Zenas BioPharma from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·9d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up - Here's Why
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up - Time to Buy...
MarketBeat·13d ago
News Placeholder
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Zenas BioPharma, Inc. (NASDAQ: ZBIO) SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation...
PR Newswire·13d ago
News Placeholder
Zenas BioPharma Highlights Obexelimab Phase 3 Win, Targets Q2 BLA Filing at Guggenheim Summit
Zenas BioPharma (NASDAQ:ZBIO) Chief Executive Officer Lonnie Moulder outlined recent clinical progress and upcoming milestones for the company's pipeline during a fireside chat at the Guggenheim...
MarketBeat·14d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Director Patricia Allen Purchases 15,700 Shares
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Patricia Allen purchased 15,700 shares of the company's stock in a transaction on Thursday, February 12th. The shares were bought at an...
MarketBeat·16d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Director Buys $109,657.60 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Patricia Allen acquired 4,160 shares of Zenas BioPharma stock in a transaction that occurred on Friday, February 13th. The stock was...
MarketBeat·17d ago
News Placeholder
Hongbo Lu Buys 25,985 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Hongbo Lu purchased 25,985 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was acquired at an...
MarketBeat·17d ago
News Placeholder
Zenas BioPharma (NASDAQ:ZBIO) Director Buys $390,145.00 in Stock
Zenas BioPharma, Inc. (NASDAQ:ZBIO - Get Free Report) Director Patricia Allen acquired 15,700 shares of Zenas BioPharma stock in a transaction that occurred on Thursday, February 12th. The stock was...
MarketBeat·17d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas BioPharma, Inc. - ZBIO INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zenas...
PR Newswire·18d ago
<
1
2
...
>

Latest ZBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.